Immediate Versus Delayed Radical Prostatectomy: Updated Outcomes Following Active Surveillance of Prostate Cancer

被引:44
|
作者
Filippou, Pauline [1 ]
Welty, Christopher J. [1 ]
Cowan, Janet E. [1 ]
Perez, Nannette [1 ]
Shinohara, Katsuto [1 ]
Carroll, Peter R. [1 ]
机构
[1] Univ Calif San Francisco, Dept Urol, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
关键词
Active surveillance; Outcomes; Pathology; Prostate cancer; Radical prostatectomy; LOW-RISK; MEN; STRAIGHTFORWARD; RECURRENCE; COHORT; TRENDS; SCORE;
D O I
10.1016/j.eururo.2015.06.011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Biopsy progression on active surveillance (AS) for prostate cancer (PCa) often reflects failure of the initial biopsy to detect cancer present at enrollment. The risks for delayed treatment among men who progress on AS are not well defined. Objective: To report outcomes for men who underwent surgery after AS compared to men who underwent immediate surgery and the influence of selection bias on this outcome. Design, setting, and participants: AS-eligible (ASE) men who underwent radical prostatectomy (RP) after a median of 20 mo of AS were compared to ASE men who underwent RP within 6 mo of diagnosis. A subset of men on AS who underwent RP after upgrade to Gleason 3 + 4 was compared to matched controls with similar pretreatment biopsy features who underwent immediate RP. Outcome measurement and statistical analysis: Rates of adverse pathology (upstaging, positive surgical margin, or Gleason upgrading) were examined. Logistic regression was used to determine associations between treatment subgroup and adverse pathology. Results and limitations: Of 157 ASE men who underwent delayed RP after AS, 54 were upgraded to Gleason 3 + 4 before surgery. ASE men who underwent immediate RP had lower probability of adverse pathology than ASE men who underwent delayed RP (hazard ratio [HR] 0.34, 95% confidence interval [CI] 0.21-0.55). The rate of adverse pathology did not differ between immediate and delayed RP patients matched for pretreatment characteristics (HR 0.79, 95% CI 0.27-2.28). The observational design of this study is its main limitation. Conclusions: When compared to men with similar pretreatment biopsy features, those who underwent delayed RP were not at higher risk of adverse pathology. Patient summary: The oncologic safety of delayed treatment when indicated for men enrolled in active surveillance for prostate cancer is important. We found that men who underwent delayed surgery had similar outcomes to men who underwent immediate prostatectomy. (C) 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 50 条
  • [21] Psychological distress and lifestyle disruption in low-risk prostate cancer patients: Comparison between active surveillance and radical prostatectomy
    Matthew, Andrew G.
    Raz, Orit
    Currie, Kristen L.
    Louis, Alyssa S.
    Jiang, Haiyan
    Davidson, Tal
    Fleshner, Neil E.
    Finelli, Antonio
    Trachtenberg, John
    JOURNAL OF PSYCHOSOCIAL ONCOLOGY, 2018, 36 (02) : 159 - 174
  • [22] Oncologic outcomes following radical prostatectomy in the active surveillance era
    Louis, Alyssa S.
    Kalnin, Robin
    Maganti, Manjula
    Pintilie, Melania
    Matthew, Andrew G.
    Finelli, Antonio
    Zlotta, Alexandre R.
    Fleshner, Neil
    Kulkarni, Girish
    Hamilton, Robert
    Jewett, Michael
    Robinette, Michael
    Alibhai, Shabbir M. H.
    Trachtenberg, John
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (7-8): : E475 - E480
  • [23] Immediate versus delayed prostatectomy: Nationwide population-based study
    Loeb, Stacy
    Folkvaljon, Yasin
    Robinson, David
    Makarov, Danil V.
    Bratt, Ola
    Garmo, Hans
    Stattin, Par
    SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (04) : 246 - 254
  • [24] Analysis of anatomopathological results of radical prostatectomy specimen of patients who answer to criteria for active surveillance of prostate cancer
    Azancot, V.
    Peyromaure, M.
    Xylinas, E.
    Descazeaud, A.
    Cornud, F.
    Vieillefond, A.
    Saighi, D.
    Amsellem-Ouazana, D.
    Debre, B.
    Zerbib, M.
    PROGRES EN UROLOGIE, 2009, 19 (09): : 619 - 623
  • [25] Sexual function with localized prostate cancer: active surveillance vs radical therapy
    van den Bergh, Roderick C. N.
    Korfage, Ida J.
    Roobol, Monique J.
    Bangma, Chris H.
    de Koning, Harry J.
    Steyerberg, Ewout W.
    Essink-Bot, Marie-Louise
    BJU INTERNATIONAL, 2012, 110 (07) : 1032 - 1039
  • [26] Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance
    Perera, Marlon
    Jibara, Ghalib
    Tin, Amy L.
    Haywood, Samuel
    Sjoberg, Daniel D.
    Benfante, Nicole E.
    Carlsson, Sigrid, V
    Eastham, James A.
    Laudone, Vincent
    Touijer, Karim A.
    Fine, Samson
    Scardino, Peter T.
    Vickers, Andrew J.
    Ehdaie, Behfar
    EUROPEAN UROLOGY FOCUS, 2023, 9 (04): : 662 - 668
  • [27] Comparison of Pathological Outcomes for Men with Low Risk Prostate Cancer from Diverse Practice Settings: Similar Results from Immediate Prostatectomy or Initial Surveillance with Delayed Prostatectomy
    Auffenberg, Gregory B.
    Linsell, Susan
    Dhir, Apoorv
    Myers, Stacie N.
    Rosenberg, Bradley
    Miller, David C.
    JOURNAL OF UROLOGY, 2016, 196 (05) : 1415 - 1420
  • [28] Medium-term Outcomes of Active Surveillance for Localised Prostate Cancer
    Selvadurai, Elizabeth D.
    Singhera, Mausam
    Thomas, Karen
    Mohammed, Kabir
    Woode-Amissah, Ruth
    Horwich, Alan
    Huddart, Robert A.
    Dearnaley, David P.
    Parker, Chris C.
    EUROPEAN UROLOGY, 2013, 64 (06) : 981 - 987
  • [29] Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance
    Whalen, Michael J.
    Pak, Jamie S.
    Lascano, Danny
    Ahlborn, David
    Matulay, Justin T.
    McKiernan, James M.
    Benson, Mitchell C.
    Wenske, Sven
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E425 - E435
  • [30] Poor association between the progression criteria in active surveillance and subsequent histopathological findings following radical prostatectomy
    Thomsen, Frederik Birkebaek
    Berg, Kasper Drimer
    Iversen, Peter
    Brasso, Klaus
    SCANDINAVIAN JOURNAL OF UROLOGY, 2015, 49 (05) : 354 - 359